Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS(TM) Study

PURPOSE: To evaluate long-term, real-world treatment patterns and outcomes of ranibizumab 0.5 mg for neovascular age-related macular degeneration (nAMD) in a Belgian cohort. PATIENTS AND METHODS: This Belgian (BE) cohort of the 5-year global observational LUMINOUS study included 229 patients with nA...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Ophthalmol
Main Authors: Leys, Anita M, Ramboer, Eva, Favreau, Mérédis, Denhaerynck, Kris, MacDonald, Karen, Abraham, Ivo, Brié, Heidi
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7277576/
https://ncbi.nlm.nih.gov/pubmed/32581505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S242547
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker